Tinidazole contraindications: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) Created page with "__NOTOC__ {{Tinidazole}} {{CMG}}; {{AE}} {{AZ}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = TINDAMAX (TINIDAZOLE) TABLET, FILM COATED [MISSION..." |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AZ}} | {{CMG}}; {{AE}} {{AZ}} | ||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = TINDAMAX (TINIDAZOLE) TABLET, FILM COATED [MISSION PHARMACAL COMPANY] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0d01539-8413-4703-94cc-d221918630a1 | publisher = | date = | accessdate = }}</ref> | ==Contraindications== | ||
The use of tinidazole is contraindicated: | |||
In patients with a previous history of hypersensitivity to tinidazole or other nitroimidazole derivatives. Reported reactions have ranged in severity from urticaria to Stevens-Johnson syndrome [see Adverse Reactions (6.1, 6.2)]. | |||
During first trimester of pregnancy [see Use in Specific Populations (8.1)]. | |||
In nursing mothers: Interruption of breast-feeding is recommended during tinidazole therapy and for 3 days following the last dose [see Use in Specific Populations (8.3)].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = TINDAMAX (TINIDAZOLE) TABLET, FILM COATED [MISSION PHARMACAL COMPANY] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0d01539-8413-4703-94cc-d221918630a1 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
{{Reflist}} | {{Reflist}} | ||
Latest revision as of 20:01, 7 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Contraindications
The use of tinidazole is contraindicated:
In patients with a previous history of hypersensitivity to tinidazole or other nitroimidazole derivatives. Reported reactions have ranged in severity from urticaria to Stevens-Johnson syndrome [see Adverse Reactions (6.1, 6.2)]. During first trimester of pregnancy [see Use in Specific Populations (8.1)]. In nursing mothers: Interruption of breast-feeding is recommended during tinidazole therapy and for 3 days following the last dose [see Use in Specific Populations (8.3)].[1]
References
Adapted from the FDA Package Insert.